Cadrenal Therapeutics, Inc.
SEC CIK 1937993 · CVKD · last insider filing 2026-06-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Pham Quang X | Director · Chief Executive Officer | filed 2023 - 2026 |
| Golden Lee Scott | Director | filed 2025 - 2025 |
| Murphy John Raymond | Director | filed 2023 - 2025 |
| Wilson Glynn | Director | filed 2023 - 2025 |
| Zelenkofske Steven | Director | filed 2023 - 2025 |
| Lisicki Robert | Director | filed 2023 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Szot Matthew K | Chief Financial Officer | filed 2023 - 2025 |
| Ferguson James J. III | Chief Medical Officer | filed 2025 - 2025 |
| Cole Jeffrey Scott | Chief Operating Officer | filed 2024 - 2025 |
| Losordo Douglas W | Chief Medical Officer | filed 2023 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.